Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

Add To Watchlist

Bullboard (TSXV:SBM)

View:

Comment by Pandoraon Jan 24, 2024 2:28am

RE:RE:New Press Release - Sirona Biochem Corporate Update January 2024

"It is our intention to launch our first consumer product containing GlycoProteMim in both Europe and North America through our subsidiary Sirona Laboratories, then expanding to other markets ...more

127

Discussion

Comment by lscfaon Jan 24, 2024 2:17am

RE:New Press Release - Sirona Biochem Corporate Update January 2024

Sounds like Sirona does not plan on licensing Glycoprotemim to others but rather will manufacture and market its own consumer products.

Discussion

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 24, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

(0)
•••

Post by PressReleaseon Jan 24, 2024 1:30am

New Press Release - Sirona Biochem Corporate Update January 2024

VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides the following update: Dear shareholders, We are pleased to provide an update on our recent milestones and strategic decisions shaping Sirona Biochem...read article.

Comment by Pandoraon Jan 24, 2024 1:28am

RE:RE:RE:FDA about TFC1067

OOps! A duplicate. The link that I put at the beginning is a duplicate of the stated "Sirona's Skincare Overview".

Discussion

Comment by Pandoraon Jan 24, 2024 1:20am

RE:RE:FDA about TFC1067

https://www.sironabiochem.com/wp-content/uploads/2021/03/Sironas-Skin-Lightening-TFC-1067.pdf Sirona Biochem’s TFC-1067 for the treatment of Dyschromia (Dark spots on the skin) Sirona Biochem has ...more

Discussion

Comment by MirrorWorldManon Jan 24, 2024 12:02am

RE:RE:FDA about TFC1067

My knee jerk reaction is focused attention on anti-aging and nothing from 1067 suggests an issue.

Discussion

Post by tylerreddickon Jan 23, 2024 10:13pm

biorun

You said: " If we understood how No 35 made it on the FDA study list, that may give us a clue as to whom is up to what in this space. It could be AbbVie or even Sirona on their own, or ...more

162

Comment by lscfaon Jan 23, 2024 5:45pm

RE:FDA about TFC1067

Your subject line should have read "1067 is a PFAS". Maybe this why R+D dropped it. Is Abbvie having 2nd thoughts?

109

Discussion

Comment by Pandoraon Jan 23, 2024 5:31pm

RE:FDA about TFC1067

And that's the non-event product with Allergen? I assume it is better to be on the list rather than not on the list. No. 35 out of 35 but I guess position on the list is not a factor? https ...more

110

Discussion

Comment by biorunon Jan 23, 2024 4:44pm

RE:RE:RE:FDA about TFC1067

The only reason why FDA would ever come into play here on 1067, according to my own diligence, is if there was a requirement to market a "pharmaceutical strength" version that goes ...more

135

Discussion